This Site Is Intended for US Healthcare Professionals Only

INDICATIONS
Important Safety Info.
Prescribing Info.

INDICATION VOQUEZNA® Triple Pak® is indicated for the treatment of Helicobacter pylori infection in adults READ MORE

ABOUT
H. PYLORI

UNMET NEED IMPORTANCE OF
ACID SUPPRESSION

MECHANISM
OF ACTION

WHAT IS A PCAB?HOW PCABs WORK

EFFICACY

STUDY DESIGN PATIENTS WITHOUT
RESISTANT STRAINS ALL-PATIENTS COHORT PATIENTS WITH
CLARITHROMYCIN-RESISTANT
STRAINS

SAFETY
PROFILE

DOSING

ACCESS AND
RESOURCES

SAVINGS CARD BlinkRx PHARMACIES VIDEO LIBRARY DOWNLOADABLE RESOURCES

CHANGE
CONDITION

Video Library

The novel mechanism of action behind PCABs

Learn how this unique acid suppressant works.

Hear from Dr. Colin Howden on efficacy and safety

Dive into the VOQUEZNA data from pHalcon-HP, a phase 3 study conducted
in H. pylori infection

Medical Information
Privacy Notice
Terms & Conditions
Contact Us
Sitemap
Manage Cookies
Do Not Sell or Share my Personal Data

VOQUEZNA, VOQUEZNA Triple Pak, VOQUEZNA Dual Pak, Phathom Pharmaceuticals, and their respective logos,
are registered trademarks of Phathom Pharmaceuticals, Inc.

This website is intended for US healthcare professionals.

Video Library

The novel mechanism of action behind PCABs

Learn how this unique acid suppressant works.

Hear from Dr. Colin Howden on efficacy and safety

Dive into the VOQUEZNA data from pHalcon-HP, a phase 3 study conducted in H. pylori infection

Dive into the VOQUEZNA data from pHalcon-HP, a phase 3 study conducted
in H. pylori infection